Crizotinib is a chemotherapeutic drug given to lung cancer patients with an ALK translocation. Crizotinib. Chemotherapeutic drug given to lung cancer patients with "ALK" translocation.
El crizotinib es un fármaco quimioterapéutico administrado a pacientes con cáncer de pulmón con una translocación del ALK. Crizotinib. Medicamento quimioterapéutico administrado a pacientes con cáncer de pulmón con translocación "ALK".
| Front | Chemotherapeutic drug given to lung cancer patients with an ALK translocation. |
|---|---|
| Back | Crizotinib. |
Learn with these flashcards. Click next, previous, or up to navigate to more flashcards for this subject.
Next card: Testing expression guides immunotherpay advanced lung cancers pd-l1
Previous card: Chemotherapeutic drug lung cancer patients egfr mutation erlotinib
Up to card list: Chapter 9: Respiratory Tract Pathology